BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35085183)

  • 1. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
    Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
    Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.
    Karaba AH; Zhu X; Liang T; Wang KH; Rittenhouse AG; Akinde O; Eby Y; Ruff JE; Blankson JN; Abedon AT; Alejo JL; Cox AL; Bailey JR; Thompson EA; Klein SL; Warren DS; Garonzik-Wang JM; Boyarsky BJ; Sitaras I; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Am J Transplant; 2022 Apr; 22(4):1253-1260. PubMed ID: 34951746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
    Subramanian V
    J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation.
    Alejo JL; Mitchell J; Chiang TP; Chang A; Abedon AT; Werbel WA; Boyarsky BJ; Zeiser LB; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Moore LW; Guha A; Huang HJ; Knight RJ; Gaber AO; Ghobrial RM; Garonzik-Wang JM; Segev DL; Bae S
    Transplantation; 2022 Oct; 106(10):e452-e460. PubMed ID: 35859275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.
    Yanis A; Haddadin Z; Spieker AJ; Waqfi D; Rankin DA; Talj R; Thomas L; Birdwell KA; Ezzell L; Blair M; Eason J; Varjabedian R; Warren CM; Nochowicz CH; Olson EC; Simmons JD; Yoder S; Guy M; Thomsen I; Chappell JD; Kalams SA; Halasa NB
    Transpl Infect Dis; 2022 Feb; 24(1):e13772. PubMed ID: 34905653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
    Chiang TP; Alejo JL; Mitchell J; Kim JD; Abedon AT; Karaba AH; Thomas L; Levan ML; Garonzik-Wang JM; Avery RK; Pekosz A; Clarke WA; Warren DS; Tobian AAR; Massie AB; Segev DL; Werbel WA
    Am J Transplant; 2022 Sep; 22(9):2254-2260. PubMed ID: 35429211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous SARS-CoV-2 infection or a third dose of vaccine elicited cross-variant neutralising antibodies in vaccinated solid-organ transplant recipients.
    Chang CC; Vlad G; Vasilescu ER; Li P; Husain SA; Silvia EA; Cohen DJ; Ratner LE; Sun WZ; Mohan S; Suciu-Foca N
    Clin Transl Immunology; 2022; 11(8):e1411. PubMed ID: 35979345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
    Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.
    Tsoutsoura P; Xagas E; Roussos S; Hatzakis A; Gourzi P; Boletis IN; Marinaki S
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374279
    [No Abstract]   [Full Text] [Related]  

  • 16. A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response.
    Karaba AH; Johnston TS; Aytenfisu TY; Akinde O; Eby Y; Ruff JE; Abedon AT; Alejo JL; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Transplantation; 2022 Jul; 106(7):1440-1444. PubMed ID: 35417115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and T-cell-mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients.
    Willauer AN; Rouster SD; Meeds HL; Jennings CL; Abdel-Hameed EA; Daria DE; Stambrook EP; Shata MTM; Sherman KE
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36930861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
    Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
    Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls.
    Søfteland JM; Gisslén M; Liljeqvist JÅ; Friman V; de Coursey E; Karason K; Ekelund J; Felldin M; Magnusson J; Baid-Agrawal S; Wallquist C; Schult A; Jacobsson H; Bergdahl A; Bemark M; Andersson LM; Holm Gunnarsson I; Stenström J; Leach S
    Am J Transplant; 2022 Apr; 22(4):1245-1252. PubMed ID: 34860447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.